Cannara Biotech (Cannara Biotech) Asset Impairment Charge : $0.00 Mil (TTM As of Feb. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Asset Impairment Charge?

Cannara Biotech's Asset Impairment Charge for the three months ended in Feb. 2024 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Feb. 2024 was $0.00 Mil.

Cannara Biotech Asset Impairment Charge Historical Data

The historical data trend for Cannara Biotech's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Asset Impairment Charge Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Asset Impairment Charge

Get a 7-Day Free Trial

0.03

Cannara Biotech Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Cannara Biotech Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Cannara Biotech Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech (Cannara Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (OTCPK:LOVFF) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

8CB0:Germany LOVE:Canada

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .